Trial Profile
Phase 3 Study to Assess the Efficacy and Safety of JTZ-951 in Anemic Patients with Chronic Kidney Disease Receiving Peritoneal Dialysis <Open Study> (SYMPHONY PD)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jan 2022
Price :
$35
*
At a glance
- Drugs Enarodustat (Primary)
- Indications Anaemia
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Japan Tobacco
- 03 Nov 2017 New trial record